Clinical Trial Update: Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at University Hospital Heidelberg is evaluating magnetic resonance-guided adaptive stereotactic body radiotherapy for liver metastases …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Hepatic Metastasis | Phase 2 | Status: RECRUITING